• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶抑制剂与 BH3 模拟物 GX15-070 的联合应用通过激活细胞凋亡和自噬发挥协同抗白血病活性。

The combination of a histone deacetylase inhibitor with the BH3-mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy.

机构信息

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Autophagy. 2010 Oct;6(7):976-8. doi: 10.4161/auto.6.7.13117. Epub 2010 Oct 23.

DOI:10.4161/auto.6.7.13117
PMID:20729640
Abstract

We analyzed the cellular and molecular effects of two different histone deacetylase inhibitors (HDACi), MGCD0103 and vorinostat, in combination with GX15-070, a BH3-mimetic, in acute myeloid leukemia (AML) cell lines and primary AML cells, and demonstrated that the combination has a synergistic antileukemia effect. We observed that in addition to apoptosis, autophagy also accounts for the observed nonapoptotic decrease of cell viability. Mechanistically, we established a role for calpain activity and ER-located caspase signaling in the induction of both autophagy and apoptosis following this combination of drugs. These findings reveal that for this specific combination, autophagy plays a positive role in inducing cytotoxicity, and that the involved ER signaling networks, as well as their clinical relevance, should be further studied in both preclinical and clinical trials of leukemia and other malignancies.

摘要

我们分析了两种不同的组蛋白去乙酰化酶抑制剂(HDACi),即 MGCD0103 和 vorinostat,与 BH3 模拟物 GX15-070 联合应用于急性髓系白血病(AML)细胞系和原代 AML 细胞中的细胞和分子效应,并证实该联合具有协同抗白血病作用。我们观察到,除了凋亡,自噬也解释了观察到的非凋亡细胞活力下降。从机制上讲,我们确定钙蛋白酶活性和内质网定位的半胱天冬酶信号在药物联合诱导自噬和凋亡中发挥作用。这些发现表明,对于这种特定的组合,自噬在诱导细胞毒性方面发挥了积极作用,并且涉及的内质网信号网络及其临床相关性应在白血病和其他恶性肿瘤的临床前和临床试验中进一步研究。

相似文献

1
The combination of a histone deacetylase inhibitor with the BH3-mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy.组蛋白去乙酰化酶抑制剂与 BH3 模拟物 GX15-070 的联合应用通过激活细胞凋亡和自噬发挥协同抗白血病活性。
Autophagy. 2010 Oct;6(7):976-8. doi: 10.4161/auto.6.7.13117. Epub 2010 Oct 23.
2
The combination of a histone deacetylase inhibitor with the Bcl-2 homology domain-3 mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy.组蛋白去乙酰化酶抑制剂与 Bcl-2 同源结构域 3 模拟物 GX15-070 的联合应用通过激活细胞凋亡和自噬来发挥协同抗白血病活性。
Clin Cancer Res. 2010 Aug 1;16(15):3923-32. doi: 10.1158/1078-0432.CCR-10-0032. Epub 2010 Jun 10.
3
Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters.伏立诺他诱导套细胞淋巴瘤细胞凋亡是通过乙酰化促凋亡 BH3 仅蛋白基因启动子介导的。
Clin Cancer Res. 2011 Jun 15;17(12):3956-68. doi: 10.1158/1078-0432.CCR-10-3412. Epub 2011 Jun 7.
4
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells.新型蛋白酶体抑制剂NPI-0052介导的半胱天冬酶8依赖性组蛋白乙酰化:白血病细胞协同作用机制
Blood. 2009 Apr 30;113(18):4289-99. doi: 10.1182/blood-2008-08-174797. Epub 2009 Jan 30.
5
Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells.靶向自噬增强组蛋白去乙酰化酶抑制剂在 t(8;21) AML 细胞中的凋亡作用。
Blood. 2013 Oct 3;122(14):2467-76. doi: 10.1182/blood-2013-05-500629. Epub 2013 Aug 22.
6
Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia.组蛋白去乙酰化酶抑制剂 MGCD0103 通过自噬作用的破坏及其在 B 细胞慢性淋巴细胞白血病中的治疗意义。
Leukemia. 2014 Aug;28(8):1636-46. doi: 10.1038/leu.2014.19. Epub 2014 Jan 14.
7
Combination of HDAC and topoisomerase inhibitors in small cell lung cancer.组蛋白去乙酰化酶(HDAC)抑制剂与拓扑异构酶抑制剂联合用于小细胞肺癌的治疗
Cancer Biol Ther. 2012 Jun;13(8):614-22. doi: 10.4161/cbt.19848. Epub 2012 Jun 1.
8
The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells.热休克蛋白90抑制剂SNX5422在诱导间变性甲状腺癌细胞死亡方面与组蛋白去乙酰化酶抑制剂具有协同活性。
Endocrine. 2016 Feb;51(2):274-82. doi: 10.1007/s12020-015-0706-7. Epub 2015 Jul 29.
9
Homoharringtonine and SAHA synergistically enhance apoptosis in human acute myeloid leukemia cells through upregulation of TRAIL and death receptors.高三尖杉酯碱和 SAHA 通过上调 TRAIL 和死亡受体协同增强人急性髓系白血病细胞的凋亡。
Mol Med Rep. 2013 Jun;7(6):1838-44. doi: 10.3892/mmr.2013.1440. Epub 2013 Apr 25.
10
EZH2i EPZ-6438 and HDACi vorinostat synergize with ONC201/TIC10 to activate integrated stress response, DR5, reduce H3K27 methylation, ClpX and promote apoptosis of multiple tumor types including DIPG.EZH2抑制剂EPZ - 6438和HDAC抑制剂伏立诺他与ONC201/TIC10协同作用,激活整合应激反应、DR5,减少H3K27甲基化、ClpX,并促进包括弥漫性内在脑桥胶质瘤(DIPG)在内的多种肿瘤类型的细胞凋亡。
Neoplasia. 2021 Aug;23(8):792-810. doi: 10.1016/j.neo.2021.06.007. Epub 2021 Jul 8.

引用本文的文献

1
The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications.组蛋白翻译后修饰在癌症及癌症免疫中的作用:功能、机制及治疗意义
Front Immunol. 2024 Nov 15;15:1495221. doi: 10.3389/fimmu.2024.1495221. eCollection 2024.
2
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia.靶向急性髓系白血病中的Bcl-2蛋白
Front Oncol. 2020 Nov 5;10:584974. doi: 10.3389/fonc.2020.584974. eCollection 2020.
3
HDAC Inhibitors in Acute Myeloid Leukemia.急性髓系白血病中的组蛋白去乙酰化酶抑制剂
Cancers (Basel). 2019 Nov 14;11(11):1794. doi: 10.3390/cancers11111794.
4
Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers.离子载体:作为抗癌药物和化学增敏剂的潜在用途。
Cancers (Basel). 2018 Sep 27;10(10):360. doi: 10.3390/cancers10100360.
5
Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML.靶向FLT3-ITD信号传导介导神经酰胺依赖性线粒体自噬并减弱急性髓系白血病中的耐药性。
Blood. 2016 Oct 13;128(15):1944-1958. doi: 10.1182/blood-2016-04-708750. Epub 2016 Aug 18.
6
Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy.B细胞和T细胞发育、生理学及恶性肿瘤中的组蛋白乙酰转移酶和组蛋白去乙酰化酶
Genes Cancer. 2015 May;6(5-6):184-213. doi: 10.18632/genesandcancer.65.
7
Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy.泛 Bcl-2 抑制剂 GX15-070(obatoclax)可减少人调节性 T 淋巴细胞而保留效应 T 淋巴细胞:其联合免疫治疗的原理。
J Immunol. 2014 Mar 15;192(6):2622-33. doi: 10.4049/jimmunol.1301369. Epub 2014 Feb 10.
8
Differentiation therapy of acute myeloid leukemia.急性髓系白血病的分化治疗。
Cancers (Basel). 2011 May 16;3(2):2402-20. doi: 10.3390/cancers3022402.
9
Bcl-2 antagonists: a proof of concept for CLL therapy.Bcl-2 拮抗剂:CLL 治疗的概念验证。
Invest New Drugs. 2013 Oct;31(5):1384-94. doi: 10.1007/s10637-013-0002-4. Epub 2013 Aug 2.
10
An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies.甲磺酸 obatoclax 治疗血液系统恶性肿瘤的循证综述。
Core Evid. 2013;8:15-26. doi: 10.2147/CE.S42568. Epub 2013 Mar 14.